U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07447297) titled 'Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation' on Nov. 23, 2025.
Brief Summary: The goal of this study to find out the efficacy of early rhythm therapy in patients with subclinical atrial fibrillation detected by Cardiac Electronic Implantable Devices.
Early rhythm therapy includes antiarrhythmic drug, cardioversion, and catheter ablation. The general control group receives general management without the above atrial fibrillation rhythm control treatment.
Researchers will compare early rhythm control groups to general control groups to see if early rhythm therapy works to reduce the atri...